The European Union’s roll-out of COVID-19 vaccines has been a disaster so far, and even European Commission President Ursula von der Leyen has conceded that the EU is “not where it wants to be” with its coronavirus immunization program.
She has admitted that “we were late to authorize,”.…“We were too optimistic when it came to massive production, and perhaps too confident that what we ordered would actually be delivered on time.”
But help seems to be on the horizon, as today suppliers of two vaccines authorized in Europe for conditional use upped their commitments.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze